Genetic Background of the Rare Yus and Gerbich Blood Group Phenotypes: Homologous Regions of the GYPC Gene Contribute to Deletion Alleles

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Background of the Rare Yus and Gerbich Blood Group Phenotypes: Homologous Regions of the GYPC Gene Contribute to Deletion Alleles research paper Genetic background of the rare Yus and Gerbich blood group phenotypes: homologous regions of the GYPC gene contribute to deletion alleles Elise Gourri,1 Gregory A. Denomme,2 Summary Yvonne Merki,1 Erwin A. Scharberg,3 The GYPC gene encodes the glycophorins C and D. The two moieties Cedric Vrignaud,4,5,6 Beat M. Frey,1 Thierry Peyrard4,5,6 express 12 known antigens of the Gerbich blood group system and and Christoph Gassner1 functionally stabilize red blood cell membranes through their intracellular 1Department of Molecular Diagnostics and interaction with protein 4.1 and p55. Three GYPC exon deletions are Research & Development, Blood Transfusion responsible for the lack of the high-frequency antigens Ge2 (Yus type, exon Service Zurich,€ Swiss Red Cross (SRC), 2 deletion), Ge2 and Ge3 (Gerbich type, exon 3 deletion), and Ge2 to 4 Zurich-Schlieren,€ Switzerland, 2Diagnostic (Leach type, exons 3 and 4 deletion), but lack exact molecular descrip- Laboratories and Blood Research Institute, Blood tion. A total of 29 rare blood samples with Yus (GE:-2,3,4) and Gerbich Center of Wisconsin, Milwaukee, WI, USA, (GE:-2,-3,4) phenotypes, including individuals of Middle-Eastern, North- 3 Institute of Transfusion Medicine and African or Balkan ancestry were examined genetically. All phenotypes could Immunohematology, Baden-Baden, German Red be explained by 4 different Yus alleles, characterized by deletions of exon 2 Cross Blood Service Baden-Wurttemberg€ - and adjacent introns, and 3 different Gerbich alleles, with deletions of exon Hessen, Baden-Baden, Germany, 4Departement 3 and adjacent introns. A 3600 base pair GYPC region, encompassing exon Centre National de Reference pour les Groupes Sanguins, Institut National de la Transfusion 2 and flanking region, shares a high degree of sequence homology with a Sanguine (INTS), 5Inserm UMR_S1134, and region flanking exon 3, probably representing an evolutionary duplication 6Laboratoire d’Excellence GR-Ex, Paris, France event. Defining the expression of Gerbich variants presently relies on rare serological reagents. Our approach substitutes the serological characteriza- Received 27 October 2016; accepted for tion with a precise genotype approach to identify the rare Yus and Gerbich publication 11 December 2016 alleles. Correspondence: Christoph Gassner, Molecular Diagnostics and Research & Development Keywords: blood groups, red cell antigens, immunohaematology, (MOC), Blood Transfusion Service, SRC, transfusion medicine, immunogenetics, molecular genetics. Zurich,€ Rutistr. 19, 8952-Schlieren, Switzerland. E-mail: [email protected] EG and GD contributed equally to this work. TP and CG also share equal responsibility for the study. Antigens of the Gerbich blood group system are the result of The GYPC gene is comprised of 4 exons and spans approxi- the expression of the integral membrane sialoglycoproteins mately 48 kilobases on the long arm of chromosome 2. glycophorin C (GPC) and glycophorin D (GPD). These gly- Unlike multi-cistronic blood group system loci, like RHD/ cophorins are important in the maintenance of the red blood RHCE and GYPA/GYPB/GYPE that are subject to a signifi- cell (RBC) plasma membrane structure through their interac- cant antigen diversity due to intergenic recombination events tion with protein 4.1 and p55, which links GPC and GPD to (Wagner & Flegel, 2014; Meyer et al, 2016), GYPC has no spectrin and actin (Alloisio et al, 1993; Marfatia et al, 1994). homologous gene and it shares little similarity with GYPA, Both proteins result from the expression of one single gene, GYPB and GYPE. It shows an alternate start codon resulting GYPC (Le Van Kim et al, 1987), with GPD representing a in the expression of GPD sialoglycoproteins (Cartron et al, 21 N-terminal amino acid truncated version of GPC and 1990). Exons 2 and 3 of GYPC and their flanking regions of encoded through an alternate transcription mechanism (Tan- approximately 3600 base pairs share 95% identity (Fig 1), ner, 1988; El-Maliki et al, 1989; Le Van Kim et al, 1996). suggesting that the exon organization originally arose from a ª 2017 John Wiley & Sons Ltd, British Journal of Haematology doi: 10.1111/bjh.14578 E. Gourri et al Fig 1. Schematic representation of GYPC and its two homologous repeat regions (light grey and black blocks). The deletions found in the Yus and Gerbich alleles are depicted as dashed lines. Diagnostic PCR-SSP products of wild-type-reactions are shown as dark grey blocks and numbered 1–8. Diagnostic gap PCRs are indicated as numbers 9–12 and 13–15, for the four Yus and three Gerbich alleles, respectively. Locations of primers for diagnostic PCRs are indicated as arrows. duplication event. Intragenic recombination events result in 2005). The mechanism of this anaemia is similar to the one nucleotide deletions encompassing one or more exons and, observed with antibodies to the Kell antigens (Denomme sometimes, their flanking regions. These regions of identity et al, 2006). In vitro studies have shown that antibodies to misalign during meiosis to create new alleles and conse- glycophorin C inhibit growth of early erythroid progenitor quently lead to new variant proteins (for a review, see cells by inducing mitochondrial depolarization and per- Daniels, 2013). turbing intracellular phosphorylation pathways; this leads to The Gerbich blood group system [International Society of actin polymerization and the induction of caspase-indepen- Blood Transfusion (ISBT) 020] is comprised of 12 antigens; dent apoptosis (Micieli et al, 2010). This is consistent with 5 low-frequency and 7 high-frequency antigens (International the early expression of glycophorin C on erythroid progeni- Society of Blood Transfusion, 2008). There are at least 3 tor cells during ontogeny. As a result, during pregnancy and variants with affected GPC expression and with or without postpartum, Gerbich antibodies not only cause classical co-expression of GPD that result in the loss of some high- macrophage-dependent erythroid cell destruction, but also prevalence antigens (Walker & Reid, 2010). The Yus (Yussef, inhibit early erythroid progenitor cell proliferation. The GE:-2,3,4) and Gerbich (GE:-2,-3,4) phenotypes are the result absence of reticulocytosis in haemolytic disease of the fetus of a deletion of exon 2 (GE*01.-02) and exon 3 (GE*01.-03) and newborn due to Gerbich maternal antibodies is consis- respectively. Another exceptional form, the Leach phenotype tent with the effect on erythroid cell proliferation (Arndt (GE:-2,-3,-4) with a complete absence of all GPC and GPD et al, 2005). proteins, is due to the absence of exons 3 and 4 (GE*01N.01) The anti-Gerbich antibodies are potentially clinically rele- or a missense mutation in the exon 3 (GE*01N.02) (Interna- vant and can cause haemolytic transfusion reactions (Baughn tional Society of Blood Transfusion, 2008; Daniels, 2013). et al, 2011). Alloimmunization among persons with the Yus The malarial merozoite form of Plasmodium falciparum uses and Gerbich phenotypes is complex. It appears that some GPC and GPD as a receptor to invade human RBCs (Patel individuals of the Gerbich phenotype make anti-Ge3 without et al, 2001; Mayer et al, 2002). Therefore, variants that alter anti-Ge2. Furthermore, the Gerbich phenotype (GE:-2,-3,4) the expression of exofacial domain probably arose from the seems to present with predominantly anti-Ge2 or anti-Ge3. natural selective pressure of the negative health effects of However, antibodies found in the Yus phenotype (GE:-2,3,4) malaria (Maier et al, 2003). Worldwide epidemiological stud- consistently show an anti-Ge2 specificity. The antibodies to ies have shown that variants of the Gerbich blood group sys- the high-prevalence antigens are the most challenging to tem are observed in two major areas, Middle East/North characterize. For Gerbich, no commercial antisera are avail- Africa/Balkans, and Southeast Asia/Indonesia/Papua New able and antibody identification relies on rare red cells and Guinea. P. falciparum infestations are common in both of alloantibodies shared among investigators. Sometimes these these areas (Mendis et al, 2001). reagents are not as they appear and errors are made in the Antibodies to Gerbich blood group antigens are important classification of new samples. Such antibody studies can ben- to consider in transfusion and pregnancy. The antibodies efit from samples that are well characterized at the molecular may be associated with haemolytic transfusion reactions and level to ensure identity between proband samples. haemolytic disease of the newborn. Gerbich antibodies are The nucleotide sequence homology between exons and particularly of clinical significance in pregnancy because they flanking regions, together with deletion variant alleles, can are often associated with a late-onset anaemia (Arndt et al, make nucleotide interrogation (genotyping) for the prediction 2 ª 2017 John Wiley & Sons Ltd, British Journal of Haematology GYPC Deletion Alleles of blood group antigens a challenge. In addition, variation in using standard reagent red cells, previously characterized Yus the location of the deletion, i.e. the specific breakpoint of the and Gerbich red cells and red cells available from a cryopre- deletion, can place the remaining information in a different served collection. context for mRNA processing and expression. We used a col- lection of alloimmunized individuals of the Yus and Gerbich Positional PCR, Sanger sequencing, and diagnostic phenotypes to characterize their nucleotide breakpoint regions PCR-SSP
Recommended publications
  • Duffy, and Mnss Group Systems
    Blood Groups – Duffy, and MNSs Group Systems Qun Lu, MD Assistant Professor Division of Transfusion Medicine Department of Pathology and Laboratory Medicine UCLA, School of Medicine Los Angeles, California 2009-03-12 Duffy Blood Group System History . 1950: Mrs. Duffy, a multiply transfused hemophiliac woman, developed an antibody not reacting with the known RBC antigens. Corresponding antigen was named after Mrs. Duffy . 1951: Fyb antibody was described in a woman with 3 pregnancies. 1955: Majority of blacks tested Fy(a-b-) . 1975: Fy(a-b-) RBCs were shown to resist infection by malaria organism Plasmodium vivax. Later: more Duffy antigens (Fy3, Fy4, Fy5, Fy6) were discovered . ISBT: 008 for the Duffy Blood Group Duffy Antigens . Most common: Fya and Fyb. Present at 6 weeks of gestation, well developed at birth – anti- Fy can cause hemolytic disease of newborn . Duffy antigens can be destroyed by enzymes such as ficin, papain, bromelain, chymotrypsin, ZZAP . When compared to Rh or Kell antigens, Duffy antigens are not very immunogenic. So, anti-Fya or anti-Fyb is not common. Fy (a-b-) is not Fy null, but homozygous for Fyb gene, they express Fyb antigen in other tissues, but not on RBCs → only will produce anti-Fya, not anti-Fyb. Fy (a-b-) is negative for Fy6 antigen which is the receptor for P. vivax (Fy6 is + when Fya + or Fyb+) Duffy Antigens . Phenotype Frequencies Chinese Phenotype Whites % Blacks % % Fy (a+b-) 17 9 90.8 Fy (a+b+) 49 1 8.9 Fy (a-b+) 34 22 0.3 Fy (a-b-) rare 68 0 White donor population: Fya: 66% Caucasians, 10% Blacks, 99% Asians Fya – units: 35% Fyb: 83% Caucasians, 23% Blacks, 18.5% Asians Fyb – units: 15% Fy3: 100% Caucasians, 32% Blacks, 99.9% Asians Duffy Antigens .
    [Show full text]
  • The Gerbich Blood Group System: a Review
    Review The Gerbich blood group system: a review P.S. Walker and M.E. Reid Antigens in the Gerbich blood group system are expressed on glycoproteins are also known as CD236R, and they attach glycophorin C (GPC) and glycophorin D (GPD), which are both to the RBC membrane through an interaction with protein encoded by a single gene, GYPC. The GYPC gene is located on 4.1R and p55. GPC and GPD contain three domains: an ex- the long arm of chromosome 2, and Gerbich antigens are in- tracellular NH2 domain, a transmembrane domain, and an herited as autosomal dominant traits. There are 11 antigens in intracellular or cytoplasmic COOH domain (Figure 1). GPC the Gerbich blood group system, six of high prevalence (Ge2, Ge3, Ge4, GEPL [Ge10*], GEAT [Ge11*], GETI [Ge12*]) and and GPD are encoded by the same gene, GYPC. When the five of low prevalence (Wb [Ge5], Lsa [Ge6], Ana [Ge7], Dha fi rst AUG initiation codon is used, GPC is encoded, whereas [Ge8], GEIS [Ge9]). GPC and GPD interact with protein 4.1R, when the second AUG is used, GPD is encoded. Thus, GPD contributing stability to the RBC membrane. Reduced lev- is a shorter version of GPC, and the amino acids in GPD els of GPC and GPD are associated with hereditary elliptocy- are identical to those found in GPC but lacking the fi rst 21 tosis, and Gerbich antigens act as receptors for the malarial amino acids at the N-terminal of GPC.9,10 parasite Plasmodium falciparum. Anti-Ge2 and anti-Ge3 have caused hemolytic transfusion reactions, and anti-Ge3 has pro- duced hemolytic disease of the fetus and newborn (HDFN).
    [Show full text]
  • Bioinformatics Analyses of Genomic Imprinting
    Bioinformatics Analyses of Genomic Imprinting Dissertation zur Erlangung des Grades des Doktors der Naturwissenschaften der Naturwissenschaftlich-Technischen Fakultät III Chemie, Pharmazie, Bio- und Werkstoffwissenschaften der Universität des Saarlandes von Barbara Hutter Saarbrücken 2009 Tag des Kolloquiums: 08.12.2009 Dekan: Prof. Dr.-Ing. Stefan Diebels Berichterstatter: Prof. Dr. Volkhard Helms Priv.-Doz. Dr. Martina Paulsen Vorsitz: Prof. Dr. Jörn Walter Akad. Mitarbeiter: Dr. Tihamér Geyer Table of contents Summary________________________________________________________________ I Zusammenfassung ________________________________________________________ I Acknowledgements _______________________________________________________II Abbreviations ___________________________________________________________ III Chapter 1 – Introduction __________________________________________________ 1 1.1 Important terms and concepts related to genomic imprinting __________________________ 2 1.2 CpG islands as regulatory elements ______________________________________________ 3 1.3 Differentially methylated regions and imprinting clusters_____________________________ 6 1.4 Reading the imprint __________________________________________________________ 8 1.5 Chromatin marks at imprinted regions___________________________________________ 10 1.6 Roles of repetitive elements ___________________________________________________ 12 1.7 Functional implications of imprinted genes _______________________________________ 14 1.8 Evolution and parental conflict ________________________________________________
    [Show full text]
  • Flow Reagents Single Color Antibodies CD Chart
    CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n
    [Show full text]
  • Quantitation of the Number of Molecules of Glycophorins C and D on Normal Red Blood Cells Using Radioiodinatedfab Fragments of Monoclonal Antibodies
    Quantitation of the Number of Molecules of Glycophorins C and D on Normal Red Blood Cells Using RadioiodinatedFab Fragments of Monoclonal Antibodies By Jon Smythe, Brigitte Gardner, andDavid J. Anstee Two rat monoclonal antibodies (BRAC 1 and BRAC 1 1 ) cytes. Fabfragments of BRAC 1 1 and ERIC 10 gave values have been produced. BRAC 1 recognizes an epitope com- of 143,000 molecules GPC per red blood cell (RBC). Fab mon to the human erythrocyte membrane glycoproteins fragments of BRAC1 gave 225,000 molecules of GPC and glycophorin C (GPC) and glycophorin D (GPD). BRAC 11 GPD per RBC. These results indicate that GPC and GPD is specific for GPC. Fabfragments of these antibodies and together are sufficiently abundantto provide membrane at- BRlC 10, a murine monoclonal anti-GPC,were radioiodin- tachment sites for all ofthe protein 4.1 in normal RBCs. ated and used in quantitative binding assays to measure 0 1994 by The American Societyof Hematology. the number of GPC and GPD molecules on normal erythro- HE SHAPE AND deformability of the mature human (200,000)" and those reported for GPC (50,000).7 This nu- Downloaded from http://ashpublications.org/blood/article-pdf/83/6/1668/612763/1668.pdf by guest on 24 September 2021 T erythrocyte is controlled by a flexible two-dimensional merical differencehas led to the suggestion that a significant lattice of proteins, which together comprise the membrane proportion of protein 4.1 in normal erythrocyte membranes skeleton.' The major components of the skeleton are spec- must be bound to sites other than GPC and GPD.3 The trin, actin, ankyrin, and protein 4.1.
    [Show full text]
  • Anti-Glycophorin C Antibody (ARG41471)
    Product datasheet [email protected] ARG41471 Package: 100 μl anti-Glycophorin C antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes Glycophorin C Tested Reactivity Hu Tested Application FACS, ICC/IF, IHC-P, IP, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name Glycophorin C Antigen Species Human Immunogen Synthetic peptide of Human Glycophorin C. Conjugation Un-conjugated Alternate Names Glycophorin-D; CD236R; GPD; Glycophorin-C; Glycoprotein beta; Glycoconnectin; GPC; PAS-2; CD antigen CD236; GE; CD236; Sialoglycoprotein D; GYPD; PAS-2' Application Instructions Application table Application Dilution FACS 1:50 ICC/IF 1:50 - 1:200 IHC-P 1:50 - 1:200 IP 1:50 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control K562 Calculated Mw 14 kDa Observed Size ~ 39 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.4), 150 mM NaCl, 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide www.arigobio.com 1/2 Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol GYPC Gene Full Name glycophorin C (Gerbich blood group) Background Glycophorin C (GYPC) is an integral membrane glycoprotein.
    [Show full text]
  • Blood Group Antigens As Receptors for Bacteria and Parasites
    Review: blood group antigens as receptors for bacteria and parasites C. LOMAS-FRANCIS Abbreviations: Gal = galactose; Glc = glucose; NeuAc lectins.4 Lectins are a class of proteins of nonimmune = N-acetylneuraminic acid; GlcNAc = N-acetylglu- origin that can combine with sugars rapidly, selective- cosamine; GalNAc = N-acetylgalactosamine; FUC = ly, and, since binding is noncovalent, reversibly. Lectins fucose; Cer = ceramide. are not confined to plants but are widespread through- out nature, and frequently appear on surfaces of cells, An important phase in the initiation of diseases caused where they are strategically positioned to combine by bacterid and parasites is the adhesion of the infectious with complementary sugars on neighboring cells. agent to tissues of the mammalian host. Adhesion is Lectins are exquisitely specific; they can distinguish mediated by specificligand-receptor interactions. Host between different monosaccharides and specifically cell receptors include a number of structures carrying bind to oligosaccharides, detecting subtle differences blood group antigens. A selection of such receptors and in complex carbohydrate structures. the attaching microorganisms, mostly bacteria, are listed Bacterial attachment to epithelial cells and to RBCs in Table 1 and will be reviewed in this article. results from the interaction of host cell receptors with bacterial surface structures known as fimbriae or pili.5 Table 1. Receptors for bacteria and parasites These submicroscopic hair-like appendages are 5 to 10 Receptors Bacteria and parasites nanometers in diameter and several hundreds of Ii Mycoplasmapneumuniae nanometers long. They protrude from the surface of P1, P, andPk P-fimbriated Escherichia coli the bacteria and serve as bacterial-binding factors by AnWj Haemophilus influenzae producing lectin-like adhesins or hemagglutinins.
    [Show full text]
  • Glycophorins and the MNS Blood Group System: a Narrative Review
    16 Review Article Page 1 of 16 Glycophorins and the MNS blood group system: a narrative review Genghis H. Lopez1,2, Catherine A. Hyland1,3, Robert L. Flower1,3 1Clinical Services and Research Division, Australian Red Cross Lifeblood, Kelvin Grove, Queensland, Australia; 2School of Medical Science, Griffith Health, Griffith University, Gold Coast, Queensland, Australia; 3School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Genghis H. Lopez, PhD. Clinical Services and Research Division, Australian Red Cross Lifeblood, 44 Musk Avenue, Kelvin Grove, Queensland 4059, Australia. Email: [email protected]. Abstract: The MNS blood group system, International Society of Blood Transfusion (ISBT) 002, is second after the ABO system. GYPA and GYPB genes encode MNS blood group antigens carried on glycophorin A (GPA), glycophorin B (GPB), or on variant glycophorins. A third gene, GYPE, produce glycophorin E (GPE) but is not expressed. MNS antigens arise from several genetic mechanisms. Single nucleotide variants (SNVs) contribute to the diversity of the MNS system. A new antigen SUMI (MNS50), p.Thr31Pro on GPA has been described in the Japanese population. Unequal crossing-over and gene conversion are the mechanisms forming hybrid glycophorins, usually from parent genes GYPA and GYPB. GYPE also contributes to gene recombination previously only described with GYPA. Recently, however, GYPE was shown to recombine with GYPB to form a GYP(B-E-B) hybrid.
    [Show full text]
  • Human Urinary Exosomes As Innate Immune Effectors
    BASIC RESEARCH www.jasn.org Human Urinary Exosomes as Innate Immune Effectors † † ‡ Thomas F. Hiemstra,* Philip D. Charles, Tannia Gracia, Svenja S. Hester,§ † ‡ | Laurent Gatto, Rafia Al-Lamki,* R. Andres Floto,* Ya Su, Jeremy N. Skepper, † ‡ Kathryn S. Lilley, and Fiona E. Karet Frankl *Department of Medicine, †Cambridge Centre for Proteome Research and Cambridge Systems Biology Centre, Department of Biochemistry, ‡Department of Medical Genetics, and |Multi-Imaging Centre, Department of Anatomy, University of Cambridge, Cambridge, United Kingdom; and §Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom ABSTRACT Exosomes are small extracellular vesicles, approximately 50 nm in diameter, derived from the endocytic pathway and released by a variety of cell types. Recent data indicate a spectrum of exosomal functions, including RNA transfer, antigen presentation, modulation of apoptosis, and shedding of obsolete protein. Exosomes derived from all nephron segments are also present in human urine, where their function is unknown. Although one report suggested in vitro uptake of exosomes by renal cortical collecting duct cells, most studies of human urinary exosomes have focused on biomarker discovery rather than exosome function. Here, we report results from in-depth proteomic analyses and EM showing that normal human urinary exosomes are significantly enriched for innate immune proteins that include antimicrobial proteins and peptides and bacterial and viral receptors. Urinary exosomes, but not the prevalent soluble urinary protein uromodulin (Tamm–Horsfall protein), potently inhibited growth of pathogenic and commensal Escherichia coli and induced bacterial lysis. Bacterial killing depended on exosome structural integrity and occurred optimally at the acidic pH typical of urine from omnivorous humans.
    [Show full text]
  • Mirepoix LLC on Behalf of Caris Life Sciences, June 22, 2020 No Revisions to These Recommendations
    0211U Oncology (pan-tumor), DNA and RNA by next generation sequencing, utilizing formalin-fixed paraffin-embedded tissue, interpretative report for single nucleotide variants, copy number alterations, tumor mutational burden, and microsatellite instability, with therapy association Submitted by Joel de Jesus, Mirepoix LLC on behalf of Caris Life Sciences, June 22, 2020 No revisions to these recommendations 0211U: MI Cancer Seek™ - NGS analysis C. Public Comment Rationale • Recommendation to crosswalk 0211U MI Cancer Seek is a combined whole transcriptome AND whole exome to 0019U (NLA=$3675.00) + 0036U sequencing test that is equivalent to (NLA=$4780.00) performing both: • 0019U: Oncology, RNA, gene expression • 1x multiplier for each by whole transcriptome sequencing, formalin-fixed paraffin-embedded tissue • Recommendation of an NLA equal to or fresh frozen tissue, predictive $8455 for 0211U algorithm reported as potential targets for therapeutic agents • 0036U: Exome (ie, somatic mutations), paired formalin-fixed paraffin-embedded tumor tissue and normal specimen, sequence analyses Submitted by Joel de Jesus, Mirepoix LLC on behalf of Caris Life Sciences, June 22, 2020 No revisions to these recommendations 0211U: MI Cancer Seek™ - NGS analysis C. 0019U* 0211U 0036U** Assay type Whole Whole Whole Whole Transcriptome Transcriptome Exome Exome Sequencing Sequencing Sequencing Sequencing Platform NGS NGS (Illumina) NGS (Illumina) RNASeq RNASeq & DNASeq DNASeq Samples tested FFPE & frozen tumor tissue FFPE tumor tissue FFPE tumor tissue
    [Show full text]
  • Proteome of Stored RBC Membrane and Vesicles from Heterozygous Beta Thalassemia Donors
    International Journal of Molecular Sciences Article Proteome of Stored RBC Membrane and Vesicles from Heterozygous Beta Thalassemia Donors Vassilis L. Tzounakas 1,†, Alkmini T. Anastasiadi 1,†, Monika Dzieciatkowska 2, Dimitrios G. Karadimas 1, Konstantinos Stamoulis 3, Issidora S. Papassideri 1, Kirk C. Hansen 2, Angelo D’Alessandro 2 , Anastasios G. Kriebardis 4,* and Marianna H. Antonelou 1,* 1 Department of Biology, School of Science, National and Kapodistrian University of Athens (NKUA), 15784 Athens, Greece; [email protected] (V.L.T.); [email protected] (A.T.A.); [email protected] (D.G.K.); [email protected] (I.S.P.) 2 Department of Biochemistry and Molecular Genetics, School of Medicine–Anschutz Medical Campus, University of Colorado, Aurora, CO 80045, USA; [email protected] (M.D.); [email protected] (K.C.H.); [email protected] (A.D.) 3 Hellenic National Blood Transfusion Centre, Acharnes, 13677 Athens, Greece; [email protected] 4 Laboratory of Reliability and Quality Control in Laboratory Hematology (HemQcR), Department of Biomedical Sciences, School of Health & Welfare Sciences, University of West Attica (UniWA), 12243 Egaleo, Greece * Correspondence: [email protected] (A.G.K.); [email protected] (M.H.A.) † These authors contributed equally to this work. Abstract: Genetic characteristics of blood donors may impact the storability of blood products. Despite higher basal stress, red blood cells (RBCs) from eligible donors that are heterozygous for Citation: Tzounakas, V.L.; beta-thalassemia traits (βThal+) possess a differential nitrogen-related metabolism, and cope better Anastasiadi, A.T.; Dzieciatkowska, with storage stress compared to the control.
    [Show full text]
  • A Comprehensive Review of Our Current Understanding of Red Blood Cell (RBC) Glycoproteins
    membranes Review A Comprehensive Review of Our Current Understanding of Red Blood Cell (RBC) Glycoproteins Takahiko Aoki Laboratory of Quality in Marine Products, Graduate School of Bioresources, Mie University, 1577 Kurima Machiya-cho, Mie, Tsu 514-8507, Japan; [email protected]; Tel.: +81-59-231-9569; Fax: +81-59-231-9557 Received: 18 August 2017; Accepted: 24 September 2017; Published: 29 September 2017 Abstract: Human red blood cells (RBC), which are the cells most commonly used in the study of biological membranes, have some glycoproteins in their cell membrane. These membrane proteins are band 3 and glycophorins A–D, and some substoichiometric glycoproteins (e.g., CD44, CD47, Lu, Kell, Duffy). The oligosaccharide that band 3 contains has one N-linked oligosaccharide, and glycophorins possess mostly O-linked oligosaccharides. The end of the O-linked oligosaccharide is linked to sialic acid. In humans, this sialic acid is N-acetylneuraminic acid (NeuAc). Another sialic acid, N-glycolylneuraminic acid (NeuGc) is present in red blood cells of non-human origin. While the biological function of band 3 is well known as an anion exchanger, it has been suggested that the oligosaccharide of band 3 does not affect the anion transport function. Although band 3 has been studied in detail, the physiological functions of glycophorins remain unclear. This review mainly describes the sialo-oligosaccharide structures of band 3 and glycophorins, followed by a discussion of the physiological functions that have been reported in the literature to date. Moreover, other glycoproteins in red blood cell membranes of non-human origin are described, and the physiological function of glycophorin in carp red blood cell membranes is discussed with respect to its bacteriostatic activity.
    [Show full text]